v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 91,187 $ 98,817
Restricted cash 114,829 105,000
Loans receivable at fair value 2,962,352 3,175,449
Capitalized software and other intangibles, net 114,735 139,801
Right of use assets - operating 21,105 30,448
Other assets 107,680 64,180
Total assets 3,411,888 3,613,695
Liabilities    
Secured financing 289,951 317,568
Asset-backed notes at fair value 1,780,005 2,387,674
Asset-backed borrowings at amortized cost 581,468 0
Acquisition and corporate financing 258,746 222,879
Lease liabilities 28,376 37,947
Other liabilities 68,938 100,028
Total liabilities 3,007,484 3,066,096
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at December 31, 2023 and December 31, 2022; 34,741,076 shares issued and 34,469,053 shares outstanding at December 31, 2023; 33,626,630 shares issued and 33,354,607 shares outstanding at December 31, 2022 7 7
Common stock, additional paid-in capital 584,555 547,799
Retained earnings (accumulated deficit) (173,849) 6,102
Treasury stock at cost, 272,023 and 272,023 shares at December 31, 2023 and December 31, 2022 (6,309) (6,309)
Total stockholders’ equity 404,404 547,599
Total liabilities and stockholders' equity $ 3,411,888 $ 3,613,695

Source

HTML PDF
XBRL
ZIP